New molecular biomarkers in differentiated thyroid carcinoma: Impact of miR-146, miR-221 and miR-222 levels in the evolution of the disease.
Ana María Gómez-PérezIsabel María Cornejo ParejaJorge García AlemánLeticia Coín AragüezArantzazu Sebastián OchoaJuan Alcaide TorresMaría Molina VegaCarlos Clu FernándezIsabel Mancha DoblasFrancisco J TinahonesPublished in: Clinical endocrinology (2019)
Elevated miR-222 and miR-146 levels are associated with poorer outcomes of the disease and may have a prognostic value in the management and follow-up of DTC.